Epkinly Injection, Solution
Product Images NDC 82705-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Epkinly (NDC 82705-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genmab Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (48 mg/0.8 mL Vial Carton)

Principal Display Panel (48 mg/0.8 mL Vial Carton)
EPKINLY 48 mg/0.8 mL injection solution for subcutaneous use, containing the active ingredient epcoritamab-bysp. The label indicates it is a prescription drug provided as a single-dose vial, distributed by Genmab US, Inc. and Abbvie. It includes instructions for use by a healthcare provider and notes to provide the enclosed Medication Guide to the patient.*
FDA Label Image

Principal Display Panel (4 mg/0.8 mL Vial Carton)

Principal Display Panel (4 mg/0.8 mL Vial Carton)
EPKINLY (epcoritamab-bysp) Injection, solution for subcutaneous injection, 4 mg/0.8 mL strength, in a single-dose vial. The label notes it is for use after dilution by a healthcare provider and includes a medication guide for patients. Labeled by Genmab US, Inc., and Abbvie.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.